This is the number one offender
Nevertheless, although BPC 157 lacks general standard neurotransmitter criteria, a network of interconnected evidence has demonstrated that BPC 157 therapy counteracts, in addition to NO-system disturbances, also dopamine, serotonin, glutamate, GABA, adrenalin/noradrenalin, and acetylcholine disturbances, whether specifically related to their receptors, including both blockade and over-activity, destruction, depletion, tolerance, and sensitization, and there is also channel disturbance counteraction [6,9]
Zllner, Tapper, et al., 2022) has shown one-to-one amplitude-ratio soft constraint between the GABA amplitude and the co-edited macromolecules at 3.0 ppm (1to1GABAsoft in Osprey) performs better for edited MRS regarding to modeling performance
Cui Q, Li J, Wang J